BioCentury
ARTICLE | Clinical News

Digene regulatory update

October 19, 1998 7:00 AM UTC

The FDA granted 510(k) marketing clearance for DIGE's Hybrid Capture CMV DNA test to diagnose CMV infection in transplant and AIDS patients. DIGE's Hybrid Capture technology uses RNA probes to bind s...